Abstract
To examine the predictable effect of inoculum size on the kinetics of the antimicrobial action of ampicillin-sulbactam, five TEM-1 beta-lactamase-producing Escherichia coli strains were studied in an in vitro dynamic model at two different initial inocula (N0S). All bacteria were exposed to ampicillin-sulbactam in a simulated system reflecting the pharmacokinetic profiles in human tissue after the administration of a single intravenous dose of ampicillin (2 g) plus sulbactam (1 g). Each strain was studied at low (4.0 to 5.2 log CFU/ml) and high (5.0 to 7.1 log CFU/ml) N0S. Despite pronounced differences in susceptibilities, the patterns of the killing curves observed with a given strain at different N0S were similar. As expected, viable bacterial counts increased with inoculum size. Striking visual contrasts in the respective curves for each organism were reflected by the area under the bacterial count-time curve (AUBC) but not by the difference between the N0 and the lowest bacterial counts (Nmin) at the nadir of the killing curve: the N0-associated changes in the AUBC on average were 75%, versus 2.5% for log N0--logNmin. To examine qualitative differences in antimicrobial effects at different N0S (i.e., the net effect of the inoculum), the difference in the high and low N0S was subtracted from each point on the killing curve obtained at the higher N0 for each strain. These adjusted curves were virtually superimposable on the observed killing curves obtained at the lower N0. Moreover, by using adjusted data, the AUBC values were similar at the two inocula, although slight (average, 11%) but systematic increases in the AUBC occurred at high N0S. Thus, there was only a weak net effect of inoculum size on the antibacterial effect of ampicillin-sulbactam. Due to similar slopes of the AUBC-log N0 plots, the antibacterial action at different N0S may be easily predicted by an approximate equation; the predicted AUBCs were unbiased and well correlated with the observed AUBCs (r = 0.997). Compiled data obtained with normalized AUBCs for different strains at different N0S yielded a positive correlation (r = 0.963) between the N0-normalized AUBC and the MIC of ampicillin-sulbactam. The adjustment and normalization procedure described might be a useful tool for revealing the net effect of the inoculum and to predict the inoculum effect if there are no qualitative differences in antimicrobial action at different inocula.
Full Text
The Full Text of this article is available as a PDF (218.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blaser J. Interactions of antimicrobial combinations in vitro: the relativity of synergism. Scand J Infect Dis Suppl. 1990;74:71–79. [PubMed] [Google Scholar]
- Blaser J., Stone B. B., Zinner S. H. Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model. Antimicrob Agents Chemother. 1985 Mar;27(3):343–349. doi: 10.1128/aac.27.3.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blaser J., Stone B. B., Zinner S. H. Two compartment kinetic model with multiple artificial capillary units. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):131–137. doi: 10.1093/jac/15.suppl_a.131. [DOI] [PubMed] [Google Scholar]
- Blaser J., Zinner S. H. In vitro models for the study of antibiotic activities. Prog Drug Res. 1987;31:349–381. doi: 10.1007/978-3-0348-9289-6_11. [DOI] [PubMed] [Google Scholar]
- Firsov A. A., Chernykh V. M., Navashin S. M. Quantitative analysis of antimicrobial effect kinetics in an in vitro dynamic model. Antimicrob Agents Chemother. 1990 Jul;34(7):1312–1317. doi: 10.1128/aac.34.7.1312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Firsov A. A., Saverino D., Savarino D., Ruble M., Gilbert D., Manzano B., Medeiros A. A., Zinner S. H. Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC. Antimicrob Agents Chemother. 1996 Mar;40(3):734–738. doi: 10.1128/aac.40.3.734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grasso S. Historical review of in-vitro models. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):99–102. doi: 10.1093/jac/15.suppl_a.99. [DOI] [PubMed] [Google Scholar]
- Sanfilippo A., Mazzoleni R. Antibacterial activity of aminosidine and of beta-lactamic antibiotics. Farmaco Prat. 1974 Jan;29(1):21–26. [PubMed] [Google Scholar]
- Satta G., Cornaglia G., Foddis G., Pompei R. Evaluation of ceftriaxone and other antibiotics against Escherichia coli, Pseudomonas aeruginosa, and Streptococcus pneumoniae under in vitro conditions simulating those of serious infections. Antimicrob Agents Chemother. 1988 Apr;32(4):552–560. doi: 10.1128/aac.32.4.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tisdale J. E., Pasko M. T., Mylotte J. M. Antipseudomonal activity of simulated infusions of gentamicin alone or with piperacillin assessed by serum bactericidal rate and area under the killing curve. Antimicrob Agents Chemother. 1989 Sep;33(9):1500–1505. doi: 10.1128/aac.33.9.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- White C. A., Toothaker R. D. Influence of ampicillin elimination half-life on in-vitro bactericidal effect. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):257–260. doi: 10.1093/jac/15.suppl_a.257. [DOI] [PubMed] [Google Scholar]